Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial

IMPORTANCE: Treatment of infantile hemangioma (IH) with topical timolol in the first 2 months of life (early proliferative phase) may prevent further growth and the need for treatment with oral propranolol. To our knowledge, no studies have determined whether beginning early treatment with timolol f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Dermatol
Main Authors: Muñoz-Garza, Fania Z., Ríos, Mónica, Roé-Crespo, Esther, Bernabeu-Wittel, José, Montserrat-García, María Teresa, Puig, Luís, Gich, Ignasi, Baselga, Eulalia
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2021
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8027942/
https://ncbi.nlm.nih.gov/pubmed/33825828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2021.0596
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados